DCRI Co-Hosts Youth Tobacco Cessation Workshop at FDA
The event drew nearly 900 registrants and discussed tobacco-cessation therapies that have been successful in youth populations, as well as gaps in knowledge surrounding e-cigarettes.
Data Suggest Results From FDA-Mandated Testing Often Not Implemented in Clinical Practice
Investigators were unsure how they would use genetic information to choose treatment choices, then often failed to follow through on their pre-stipulated plan to use this information.
DCRI Research Contributes to FDA Approval of First Drug for Rare Disease in Pediatric Patients
The team used pharmacokinetic modeling to assess how the drug would behave in children, leading to FDA approval without conducting a pediatric clinical trial.
Study Examines Predictors of Transplant or Death in IPF Patients
Researchers examined clinical factors at the time of a patient’s enrollment in the IPF-PRO registry that might predict lung transplant or death.
DCRI study honored as practice-changing by New England Journal of Medicine
Duke joins Baseline Health Consortium to get patients more involved in research
DCRI joins Digital Therapeutics Alliance
Use of supportive palliative care lags for heart patients
Patients tend to be sicker and miss full benefits by the time palliative care is provided.
New professional development program aims to advance women’s clinical research careers
DCRI receives CRO Leadership Awards for fourth year
The DCRI was recognized in five categories, including Capabilities, Compatibility, Expertise, Phase IV, and Reliability.